Drugs / mRNA-1405
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05992935 | Aug 2023 → Sep 2026 overdue | norovirus infectious disease | ModernaTX, Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1405 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05992935 ↗ |
| Modality | Messenger RNA (mRNA) | “mRNA-1403 and mRNA-1405, Multivalent Candidate Vaccines” NCT05992935 ↗ |